REQUEST A DEMO
Total
USD $0.00
Search more companies

Qualipharm Laboratorio Farmaceutico S.A. (Ecuador)

Main Activities: Toilet Preparation Manufacturing
Full name: Qualipharm Laboratorio Farmaceutico S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Qualipharm Laboratorio Farmaceutico S.A. is an enterprise based in Ecuador. Its main office is in Quito. It operates in the Toilet Preparation Manufacturing sector. It was established on October 24, 2008. There are currently 242 (2021) people employed by Qualipharm Laboratorio Farmaceutico S.A.. In 2022, the company reported a net sales revenue increase of 19.04%. During that time, Qualipharm Laboratorio Farmaceutico S.A.’s total assets grew by 37.31%. In, 2022, the company’s net profit margin decreased by 1.4%.

Headquarters
Av. Manuel Cordova Galarza Oe4-175, Fierro Inmobiliaria Bldg.
Quito; Pichincha;

Contact Details: Purchase the Qualipharm Laboratorio Farmaceutico S.A. report to view the information.

Website: http://www.qualipharmlab.com

Basic Information
Total Employees:
Purchase the Qualipharm Laboratorio Farmaceutico S.A. report to view the information.
Outstanding Shares:
Purchase the Qualipharm Laboratorio Farmaceutico S.A. report to view the information.
Registered Capital:
Purchase the Qualipharm Laboratorio Farmaceutico S.A. report to view the information.
Incorporation Date:
October 24, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Qualipharm Laboratorio Farmaceutico S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
19.04%
Total operating revenue
15.62%
Operating profit (EBIT)
30.31%
EBITDA
51.91%
Net Profit (Loss) for the Period
-5.37%
Total assets
37.31%
Total equity
23.13%
Operating Profit Margin (ROS)
1.38%
Net Profit Margin
-1.4%
Return on Equity (ROE)
-6.98%
Debt to Equity Ratio
50.8%
Quick Ratio
0.04%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?